Immunovia AB (publ) (STO:IMMNOV)
0.0371
+0.0042 (12.77%)
Nov 19, 2026, 1:54 PM CET
Immunovia AB Revenue
Immunovia AB had revenue of 888.00K SEK in the quarter ending September 30, 2026, with 779.21% growth. This brings the company's total for the last twelve months to 2.07M, up 129.20% year-over-year. In the year 2025, Immunovia AB had annual revenue of 752.00K, down -55.61%. That makes Immunovia AB the 45,548th largest company in the world by revenue and 724th in Sweden.
Revenue (ttm)
2.07M
Revenue Growth
+129.20%
P/S Ratio
11.33
Revenue / Employee
102.79K
Employees
19
Market Cap
24.96M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 752.00K | -942.00K | -55.61% |
| Dec 31, 2024 | 1.69M | -108.00K | -5.99% |
| Dec 31, 2023 | 1.80M | 598.00K | 49.67% |
| Dec 31, 2022 | 1.20M | 248.00K | 25.94% |
| Dec 31, 2021 | 956.00K | -30.00K | -3.04% |
| Dec 31, 2020 | 986.00K | 172.00K | 21.13% |
| Dec 31, 2019 | 814.00K | -263.00K | -24.42% |
| Dec 31, 2018 | 1.08M | -23.17M | -95.56% |
| Dec 31, 2017 | 24.25M | -254.10K | -1.04% |
| Dec 31, 2016 | 24.50M | 7.50M | 44.07% |
| Dec 31, 2015 | 17.01M | 16.47M | 3,084.89% |
| Dec 31, 2014 | 534.00K | -646.09K | -54.75% |
| Dec 31, 2013 | 1.18M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.46B |
| Swedish Orphan Biovitrum AB | 31.97B |
| Sectra AB | 3.74B |
| Camurus AB | 2.42B |
| ScandiDos AB | 48.90M |
| ExpreS2ion Biotech Holding AB | 24.24M |
| Perpetua Medical AB | 19.58M |
| Orexo AB | 12.50M |
Immunovia AB News
- 16 days ago - Immunovia AB Earnings Call Transcript: Q3 2026 - Transcripts
- 16 days ago - Immunovia AB Quarterly report: Q3 2026 - Filings
- 16 days ago - Immunovia AB Slides: Q3 2026 - Filings
- 17 days ago - Immunovia AB Transcript: Investor update - Transcripts
- 3 months ago - Immunovia AB Earnings Call Transcript: Q2 2026 - Transcripts
- 3 months ago - Immunovia AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Immunovia AB Slides: Q2 2026 - Filings
- 6 months ago - Immunovia AB Earnings Call Transcript: Q1 2026 - Transcripts